🇺🇸 FDA

Company profile · Sponsor

SPRUCE

SPRUCE BIOSCIENCES, INC.

SPRB · NYSE pharma SOUTH SAN FRANCISCO, CA, USA
Pipeline
5
Drugs
0
Patents
8

Quick answer

SPRUCE (SPRB) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker SPRB
Exchange NYSE
Company type pharma
Headquarters SOUTH SAN FRANCISCO, CA, USA
SEC CIK 0001683553

Pipeline (5)

Search pipeline →

  1. Tralesinidase alfa (TA)

    SPRUCE

    MPS IIIB

    phase 3 small molecule active

    1 trial

  2. SPR001

    SPRUCE

    Congenital Adrenal Hyperplasia

    phase 2 small molecule completed

    2 trials

  3. Tildacerfont

    SPRUCE

    Congenital Adrenal Hyperplasia

    phase 2 small molecule terminated

    1 trial

  4. Tildacerfont

    SPRUCE

    Polycystic Ovary Syndrome

    phase 2 small molecule terminated

    1 trial

  5. Tildacerfont/Placebo

    SPRUCE

    Congenital Adrenal Hyperplasia

    phase 2 small molecule terminated

    2 trials

Patents (8)

Search patents →

  1. US 12115166

    Corticotropin releasing factor receptor antagonists

    Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12098152

    Methods and compositions for treating polycystic ovary syndrome

    Expires Mon Sep 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11858932

    Methods and compositions for treating polycystic ovary syndrome

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11351177

    Corticotropin releasing factor receptor antagonists

    Expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11344557

    Corticotropin releasing factor receptor antagonists

    Expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11311549

    Corticotropin releasing factor receptor antagonists

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11304950

    Methods for treating testicular and ovarian adrenal rest tumors

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11007201

    Corticotropin releasing factor receptor antagonists

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is SPRUCE?

SPRUCE (SPRB) is a pharma company. headquartered in SOUTH SAN FRANCISCO, CA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does SPRUCE sponsor?

We track 5 ClinicalTrials.gov-linked programs for SPRUCE, including Tralesinidase alfa (TA) and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does SPRUCE company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.